The Beta Agonist Lung Injury TrIal (BALTI)--prevention trial protocol. by Perkins, G, Park, D, Alderson, D, Cooke, M, Gao, F, Gates, S, Lamb, S, Mistry, D, Thickett, DR

Effect of intravenous β-2 agonist treatment on clinical outcomes in acute respiratory distress syndrome (BALTI-2): a multicentre, randomised controlled trial. by Gao Smith, F, Perkins, G, Gates, S, Young, D, McAuley, D, Tunnicliffe, W, Khan, Z, Lamb, S

Beta Agonist Lung Injury TrIal-2 (BALTI-2) trial protocol: a randomised, double-blind, placebo-controlled of intravenous infusion of salbutamol in the acute respiratory distress syndrome. by Perkins, G, Gates, S, Lamb, S, McCabe, C, Young, D, Gao, F

“…The Beta Agonist Lung Injury TrIal (BALTI-2) is a multicentre, pragmatic, randomised, double-blind, placebo-controlled clinical trial which aims to determine if sustained treatment with intravenous (IV) salbutamol will improve survival in ARDS. …”

Beta-Agonist Lung injury TrIal-2 (BALTI-2): a multicentre, randomised, double-blind, placebo-controlled trial and economic evaluation of intravenous infusion of salbutamol versus placebo in patients with acute respiratory distress syndrome. by Gates, S, Perkins, G, Lamb, S, Kelly, C, Thickett, DR, Young, J, McAuley, D, Snaith, C, McCabe, C, Hulme, C, Gao Smith, F

“…The Beta-Agonist Lung injury TrIal-2 (BALTI-2) was initiated to evaluate the effects of this intervention on mortality in patients with ARDS. …”

Beta-Agonist Lung injury TrIal-2 (BALTI-2): a multicentre, randomised, double-blind, placebo-controlled trial and economic evaluation of intravenous infusion of salbutamol versus placebo in patients with acute respiratory distress syndrome. by Gates, S, Perkins, G, Lamb, S, Kelly, C, Thickett, DR, Young, J, McAuley, D, Snaith, C, McCabe, C, Hulme, C, Gao Smith, F

“…The Beta-Agonist Lung injury TrIal-2 (BALTI-2) was initiated to evaluate the effects of this intervention on mortality in patients with ARDS. …”